Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Moellering

Showing results (191-200 of 235) with videos related to

Pageof 24
Sort By:
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
The Journal of Clinical Investigation|August 1, 1978
Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergismD J Krogstad, T R Korfhagen, R C Moellering, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faeciumG M Eliopoulos, C Wennersten, S Zighelboim-Daum, et al.
The American Journal of Medicine|April 1, 1978
Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoresesR H Glew, H R Buckley, H M Rosen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agentG M Eliopoulos, C B Wennersten, G Cole, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella sppL A Collins, C B Wennersten, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticG M Eliopoulos, S Willey, E Reiszner, et al.
Acta Chirurgica Scandinavica. Supplementum|January 1, 1976
Value of prospective Candida precipitins in hyperalimented patientsH M Rosen, R H Glew, H R Buckley, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1978
Unreliability of fever and leukocytosis in the diagnosis of infection after cardiac valve surgeryD M Bell, D A Goldmann, C C Hopkins, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis modelL B Rice, C T Eliopoulos, J D Yao, et al.
Pageof 24

Showing results (191-200 of 235) with videos related to

Sort By:
Pageof 24
Diagnostic Microbiology and Infectious Disease|November 1, 1989
Comparative in vitro activity of piperacillin combined with the beta-lactamase inhibitor tazobactam (YTR 830)G M Eliopoulos, K Klimm, M J Ferraro, et al.
The Journal of Clinical Investigation|August 1, 1978
Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergismD J Krogstad, T R Korfhagen, R C Moellering, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1988
High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faeciumG M Eliopoulos, C Wennersten, S Zighelboim-Daum, et al.
The American Journal of Medicine|April 1, 1978
Serologic tests in the diagnosis of systemic candidiasis. Enhanced diagnostic accuracy with crossed immunoelectrophoresesR H Glew, H R Buckley, H M Rosen, et al.
Antimicrobial Agents and Chemotherapy|April 1, 1995
In vitro activity of A-86719.1, a novel 2-pyridone antimicrobial agentG M Eliopoulos, C B Wennersten, G Cole, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Comparative activities of piperacillin and tazobactam against clinical isolates of Legionella sppL A Collins, C B Wennersten, M J Ferraro, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1986
In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibioticG M Eliopoulos, S Willey, E Reiszner, et al.
Acta Chirurgica Scandinavica. Supplementum|January 1, 1976
Value of prospective Candida precipitins in hyperalimented patientsH M Rosen, R H Glew, H R Buckley, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 1, 1978
Unreliability of fever and leukocytosis in the diagnosis of infection after cardiac valve surgeryD M Bell, D A Goldmann, C C Hopkins, et al.
Diagnostic Microbiology and Infectious Disease|February 11, 1992
In vivo activity of the combination of daptomycin and fosfomycin compared with daptomycin alone against a strain of Enterococcus faecalis with high-level gentamicin resistance in the rat endocarditis modelL B Rice, C T Eliopoulos, J D Yao, et al.
Pageof 24